NPIC
PBH icon

Neumeier Poma Investment Counsel’s Prestige Consumer Healthcare PBH Stock Holding History

Neumeier Poma Investment Counsel’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-222,495
Closed -$17.8M – 44
2025
Q2 		$17.8M Buy
222,495
+121,145
+120% +$10.1M 1.65% 29
2025
Q1 		$8.71M Buy
+101,350
New +$8.31M 0.94% 38

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neumeier Poma Investment Counsel's PBH Position: Q3 2025 in Review

Neumeier Poma Investment Counsel sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 222,495 shares — an estimated $17.8M sold.

Neumeier Poma Investment Counsel first reported a position in PBH in Q1 2025 and held it in 2 quarters. The position peaked at $17.8M in Q2 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Neumeier Poma Investment Counsel reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Neumeier Poma Investment Counsel sold 222,495 Prestige Consumer Healthcare shares in Q3 2025, an estimated $17.8M.
  • Neumeier Poma Investment Counsel first reported a position in Prestige Consumer Healthcare in Q1 2025 and held it in 2 quarters.
  • Neumeier Poma Investment Counsel's Prestige Consumer Healthcare position peaked at $17.8M in Q2 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Neumeier Poma Investment Counsel's 13F filing for Q3 2025, filed 12 Nov 2025.